Skip to content
OpenCapital
Get started

Lyell Immunopharma, Inc. LYEL Q4 2024 Annual earnings

Reported March 11, 2025 · Before market open

Revenue$11.0K
EPS-$0.72Miss by $0.54
EPS estimate-$0.18

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$4.6K
EPS estimate-$2.02

Versus estimates

Revenue

Q1 2026$2.0KMiss by $1.0KQ4 2025$6.0KMiss by $9.3KQ3 2025$15.0KQ2 2025$8.0KBeat by $4.0KQ1 2025$7.0K
Q4 2024$11.0K

Diluted EPS

Q1 2026-$1.10Beat by $1.68Q4 2025-$7.68Miss by $5.53Q3 2025-$2.13Beat by $0.68Q2 2025-$2.89Beat by $0.91Q1 2025-$3.60Beat by $0.20
Q4 2024-$0.72Miss by $0.54

Ask the moment Lyell Immunopharma, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Lyell Immunopharma, Inc. report Q4 2024 earnings?
Lyell Immunopharma, Inc. (LYEL) reported Q4 2024 earnings on March 11, 2025 before market open.
What were Lyell Immunopharma, Inc.'s Q4 2024 revenue and EPS?
Lyell Immunopharma, Inc. reported revenue of $11.0K and eps of $-0.72 for Q4 2024.
Did Lyell Immunopharma, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.18 by $0.54.
Where can I find Lyell Immunopharma, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0001628280-25-011978) directly on SEC EDGAR. The filing index links above go to sec.gov.